前沿论文｜CELL INTELLIGENCE

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

PubMed 2026/06/26 发表J Exp MedQ1 · IF 11.6（JCR 2025）

IL-7: a potential next-generation adjuvant for immune cell therapies.

PubMed 2026/01/02 发表Front ImmunolQ1 · IF 7（JCR 2025）

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

PubMed 2025/09/10 发表Nat CommunQ1 · IF 18.1（JCR 2025）

Clinical development of immuno-oncology therapeutics.

PubMed 2025/03/06 发表Cancer LettQ1 · IF 11.8（JCR 2025）

The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials.

PubMed 2024/09/27 发表Front OncolQ2 · IF 3.4（JCR 2025）

Emerging molecular therapies in the treatment of bladder cancer.

PubMed 2024/08/29 发表Explor Target Antitumor Ther

Genitourinary cancers updates: highlights from ASCO 2023.

PubMed 2023/11/21 发表J Hematol OncolQ1 · IF 47.8（JCR 2025）

Highlights into historical and current immune interventions for cancer.

PubMed 2023/02/27 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.

PubMed 2022/01/01 发表Cancer Treat Res

Cancer/testis antigens: from serology to mRNA cancer vaccine.

PubMed 2021/04/25 发表Semin Cancer BiolQ1 · IF 20.3（JCR 2025）

前沿论文 10